DrugDashboards
← Home
Manufacturing facility

Glenmark Pharmaceuticals Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step β€” so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Plot No. 2, Phase-2, Pharma Zone SEZ Pithampur, Dhar, Madhya Pradesh 454775, India (IND)
Operations here
analysislabelmanufacturepack
FDA identifiers
FEI 3008565058 Β· DUNS 862603186

Recent inspection flagged official action

FDA classified an inspection here as OAI (official action indicated) within the last two years β€” the strongest public warning signal a facility gets. This plant is listed on labels for 52 drugs. A supply problem here can ripple to all of them.

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • OAIDrug Quality Assurance2025-02-14
  • NAIDrug Quality Assurance2020-02-25
  • NAIDrug Quality Assurance2019-09-13
  • VAIDrug Quality Assurance2018-05-24
  • NAIDrug Quality Assurance2017-08-26
  • VAIDrug Quality Assurance2016-02-26
  • VAIDrug Quality Assurance2015-07-24
  • NAIDrug Quality Assurance2013-10-25

Drugs this plant is listed as making

52 distinct drugs across 159 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.

Glenmark Pharmaceuticals Limited β€” facility profile Β· DrugDashboards